Concepedia

Larry M. Weisenthal

LM

21

Publications

1.2K

Citations

17

H-Index

1971

Active since

Affiliations

Atotech (United States)(Current)

University of Michigan

United States Department of Veterans Affairs

California State University, Long Beach

University of California, Irvine

Larry M. Weisenthal is an author at Atotech (United States) specializing in medicine, cancer research, and pharmacology.

Top concepts

Publications per year

1971–2008

21

Publications

21

A novel dye exclusion method for testing in vitro chemosensitivity of human tumors.

Larry M. Weisenthal, J. A. Marsden, Patricia L. Dill et al. · PubMed · 1983 · 239 citations

, , +16

Clonogenic and nonclonogenic in vitro chemosensitivity assays.

Larry M. Weisenthal, M. E. Lippman · PubMed · 1985 · 204 citations

, , +19

Highly Specific Prediction of Antineoplastic Drug Resistance With an In Vitro Assay Using Suprapharmacologic Drug Exposures

David H. Kern, Larry M. Weisenthal · JNCI Journal of the National Cancer Institute · 1990 · 176 citations

Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity.

Larry M. Weisenthal, Patricia L. Dill, N. B. Kurnick et al. · PubMed · 1983 · 154 citations

, , +19

Delayed Hemorrhage after Percutaneous Liver Biopsy

Cheryl M. Reichert, Larry M. Weisenthal, Harvey G. Klein · Journal of Clinical Gastroenterology · 1983 · 58 citations

, , +13

Rows per page

1–5 of 21